ArticleBritish journal of cancer2019

A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.

Gabriel Mak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.